Skip to main content
. 2023 May 2;40(5):417–426. doi: 10.1007/s40266-023-01024-6

Table 2.

(a) Top five indications with the highest increase in the mean consensus coefficient. (b) Top five indications with the highest or lowest mean consensus coefficient

Mean consensus coefficient (range) p value (Wilcoxon–Mann–Whitney test)
EURO-FORTA version 2 EURO-FORTA version 1
BPSD: depression 0.907 (0.901–0.918) 0.710 (0.546–0.823)
BPSD: paranoia, hallucination 0.953 (0.922–0.988) 0.840 (0.641–0.928) < 0.05
BPSD: sleep disorders 0.938 (0.929–0.948) 0.838 (0.658–0.961)
Parkinson’s disease 0.978 (0.954–1.000) 0.886 (0.706–1.000) < 0.05
Bipolar disorder 0.970 (0.925–1.000) 0.909 (0.723–0.983)
EURO-FORTA version 2
Mean consensus coefficient (range)
Highest mean consensus coefficient
Oncological diseases: solid tumors 0.997 (0.975–1.000)
Oncological supportive therapy 0.992 (0.995–1.000)
Oncological diseases: hematological neoplasias 0.983 (0.975–1.000)
Acute coronary syndrome 0.981 (0.952–1.000)
Epilepsy 0.979 (0.924–1.000)
Lowest mean consensus coefficient
BPSD: depression 0.907 (0.901–0.918)
Atrial fibrillation 0.907 (0.732–1.000)
Type II diabetes mellitus 0.919 (0.843–1.000)
BPSD: sleep disorders 0.938 (0.929–0.948)
Osteoporosis 0.941 (0.889–1.000)

FORTA Fit fOR The Aged, BPSD behavioral and psychological symptoms of dementia